CVT-2738
CVT-2738 is an orally active metabolite of Ranolazine (HY-B0280) . CVT-2738 has a protective effect against Isoprenaline (HY-108353) -induced myocardial ischemia in mice. CVT-2738 can be used in myocardial ischemia research[1].
Product Specifications
CAS Number
[5294-61-1]
Product Name Alternative
RS-94287
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Drug Metabolite
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/cvt-2738.html
Purity
99.81
Solubility
DMSO : 10 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(NC1=C(C)C=CC=C1C)CN2CCNCC2
Molecular Formula
C14H21N3O
Molecular Weight
247.34
Precautions
H302, H315, H319, H335
References & Citations
[1]Yao Z, et al. Synthesis of ranolazine metabolites and their anti-myocardial ischemia activities. Chem Pharm Bull (Tokyo) . 2009 Nov;57 (11) :1218-22.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1453243-01 0.02 mg (E-Coli)
Recombinant Bacillus subtilis Uncharacterized protein ybbK (ybbK)
Ask
View Details MBS1453243-02 0.1 mg (E-Coli)
Recombinant Bacillus subtilis Uncharacterized protein ybbK (ybbK)
Ask
View Details 
MBS1453243-03 0.02 mg (Yeast)
Recombinant Bacillus subtilis Uncharacterized protein ybbK (ybbK)
Ask
View Details 
MBS1453243-04 0.1 mg (Yeast)
Recombinant Bacillus subtilis Uncharacterized protein ybbK (ybbK)
Ask
View Details MBS1453243-05 0.02 mg (Baculovirus)
Recombinant Bacillus subtilis Uncharacterized protein ybbK (ybbK)
Ask
View Details 
MBS1453243-06 0.02 mg (Mammalian-Cell)
Recombinant Bacillus subtilis Uncharacterized protein ybbK (ybbK)
Ask
View Details